Explore ›
Finding
Finding
improvement
After cessation of oral medications at 6 months, significantly fewer women in the anticholinergic group maintained adequate symptom control at month 7 compared to onabotulinumtoxinA (50% vs 62%, P=0.006), with a numerically but not statistically significant difference persisting at 12 months (25% vs 38%, P=0.61).
| Effect size | 62% vs 50% adequate control at 7 months; 38% vs 25% at 12 months |
| Follow-up | 12 months |
| Comparator | Anticholinergic therapy (solifenacin/trospium XR) — oral medications discontinued at 6 months |
| Effect summary | improvement; 62% vs 50% adequate control at 7 months; 38% vs 25% at 12 months |
Connected entities
Conditions
Outcomes
Populations
Source
PMC3543828
Anticholinergic Therapy vs. OnabotulinumtoxinA for Urgency Urinary Incontinence